Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Analysis of current data on the use of intravenous immunoglobulins in management of pemphigus vulgaris.

Engineer L, Bhol KC, Ahmed AR.

J Am Acad Dermatol. 2000 Dec;43(6):1049-57.

PMID:
11100022
2.

Analysis of current data on the use of methotrexate in the treatment of pemphigus and pemphigoid.

Gürcan HM, Ahmed AR.

Br J Dermatol. 2009 Oct;161(4):723-31. doi: 10.1111/j.1365-2133.2009.09246.x. Review.

PMID:
19548961
3.

Mitoxantrone: a review of its use in multiple sclerosis.

Scott LJ, Figgitt DP.

CNS Drugs. 2004;18(6):379-96. Review.

PMID:
15089110
4.

[How intravenous immunoglobulin therapy works in pemphigus].

Aoyama Y.

Nihon Rinsho. 2012 Aug;70(8):1437-43. Review. Japanese.

PMID:
22894086
5.

Rituximab: a monoclonal antibody to CD20 used in the treatment of pemphigus vulgaris.

El Tal AK, Posner MR, Spigelman Z, Ahmed AR.

J Am Acad Dermatol. 2006 Sep;55(3):449-59. Review.

PMID:
16908351
6.
7.

Treatment strategies for pemphigus vulgaris in Japan.

Hashimoto T.

Expert Opin Pharmacother. 2008 Jun;9(9):1519-30. doi: 10.1517/14656566.9.9.1519 . Review.

PMID:
18518782
8.
9.
10.

Immunoglobulin treatment in epilepsy, a review of the literature.

van Engelen BG, Renier WO, Weemaes CM, Gabreels FJ, Meinardi H.

Epilepsy Res. 1994 Dec;19(3):181-90. Review.

PMID:
7698094
11.
12.

Management of pemphigus in pediatric patients.

Gürcan H, Mabrouk D, Razzaque Ahmed A.

Minerva Pediatr. 2011 Aug;63(4):279-91. Review.

PMID:
21909064
13.

Kawasaki disease: an update.

Gedalia A.

Curr Rheumatol Rep. 2002 Feb;4(1):25-9. Review.

PMID:
11798979
14.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
15.

Intravenous immune globulin for inducing remissions in systemic lupus erythematosus.

Heyneman CA, Gudger CA, Beckwith JV.

Ann Pharmacother. 1997 Feb;31(2):242-4. Review.

PMID:
9034428
16.

Oral pemphigus: long term behaviour and clinical response to treatment with deflazacort in sixteen cases.

Mignogna MD, Lo Muzio L, Mignogna RE, Carbone R, Ruoppo E, Bucci E.

J Oral Pathol Med. 2000 Apr;29(4):145-52. Review.

PMID:
10766391
17.

Treatment of severe pemphigus with rituximab: report of 12 cases and a review of the literature.

Cianchini G, Corona R, Frezzolini A, Ruffelli M, Didona B, Puddu P.

Arch Dermatol. 2007 Aug;143(8):1033-8. Review.

PMID:
17709662
18.

Pemphigus vulgaris in pregnancy: analysis of current data on the management and outcomes.

Kardos M, Levine D, Gürcan HM, Ahmed RA.

Obstet Gynecol Surv. 2009 Nov;64(11):739-49. doi: 10.1097/OGX.0b013e3181bea089. Review.

PMID:
19849866
19.

Analysis of current therapy and clinical outcome in childhood pemphigus vulgaris.

Mabrouk D, Ahmed AR.

Pediatr Dermatol. 2011 Sep-Oct;28(5):485-93. doi: 10.1111/j.1525-1470.2011.01514.x. Review.

PMID:
21883426
20.

Oral pemphigus vulgaris: a review of the literature and a report on the management of 12 cases.

Robinson JC, Lozada-Nur F, Frieden I.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997 Oct;84(4):349-55. Review.

PMID:
9347496
Items per page

Supplemental Content

Support Center